| Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential A Anemone, L Consolino, L Conti, P Irrera, MY Hsu, D Villano, W Dastrù, ... British journal of cancer 124 (1), 207-216, 2021 | 54 | 2021 |
| Noninvasive evaluation of renal pH homeostasis after ischemia reperfusion injury by CEST‐MRI DL Longo, JC Cutrin, F Michelotti, P Irrera, S Aime NMR in Biomedicine 30 (7), e3720, 2017 | 50 | 2017 |
| Non-invasive investigation of tumor metabolism and acidosis by MRI-CEST imaging L Consolino, A Anemone, M Capozza, A Carella, P Irrera, A Corrado, ... Frontiers in Oncology 10, 161, 2020 | 46 | 2020 |
| A fast multislice sequence for 3D MRI‐CEST pH imaging D Villano, F Romdhane, P Irrera, L Consolino, A Anemone, M Zaiss, ... Magnetic Resonance in Medicine 85 (3), 1335-1349, 2021 | 34 | 2021 |
| Flip-angle based ratiometric approach for pulsed CEST-MRI pH imaging F Arena, P Irrera, L Consolino, SC Serra, M Zaiss, DL Longo Journal of magnetic resonance 287, 1-9, 2018 | 22 | 2018 |
| Dual assessment of kidney perfusion and pH by exploiting a dynamic CEST‐MRI approach in an acute kidney ischemia–reperfusion injury murine model P Irrera, L Consolino, JC Cutrin, FG Zöllner, DL Longo NMR in Biomedicine 33 (6), e4287, 2020 | 18 | 2020 |
| Evaluation of a similarity anisotropic diffusion denoising approach for improving in vivo CEST‐MRI tumor pH imaging F Romdhane, D Villano, P Irrera, L Consolino, DL Longo Magnetic Resonance in Medicine 85 (6), 3479-3496, 2021 | 13 | 2021 |
| Orthotopic induction of CH 157 MN convexity and skull base meningiomas into nude mice using stereotactic surgery and MRI characterization F La Cava, A Fringuello Mingo, P Irrera, A Di Vito, A Cordaro, C Brioschi, ... Animal Models and Experimental Medicine 2 (1), 58-63, 2019 | 7 | 2019 |
| Intraperitoneal delivery of iopamidol to assess extracellular pH of orthotopic pancreatic tumor model by CEST-MRI BV Jardim-Perassi, P Irrera, JYC Lau, M Budzevich, CJ Whelan, ... Contrast Media & Molecular Imaging 2023, 2023 | 6 | 2023 |
| In vivo MRI-CEST tumor pH imaging detects resistance to proton pump inhibitors in human prostate cancer murine models P Irrera, L Consolino, M Roberto, M Capozza, C Dhakan, A Carella, ... Cancers 14 (19), 4916, 2022 | 6 | 2022 |
| Di-Pyridine-Containing Macrocyclic Triamide Fe (II) and Ni (II) Complexes as ParaCEST Agents RN Pradhan, P Irrera, F Romdhane, SK Panda, DL Longo, J Torres, ... Inorganic Chemistry 61 (42), 16650-16663, 2022 | 6 | 2022 |
| Investigating plasma volume expanders as novel macromolecular MRI‐CEST contrast agents for tumor contrast‐enhanced imaging L Consolino, P Irrera, F Romdhane, A Anemone, DL Longo Magnetic Resonance in Medicine 86 (2), 995-1007, 2021 | 6 | 2021 |
| Renal pH imaging using chemical exchange saturation transfer (CEST) MRI: basic concept DL Longo, P Irrera, L Consolino, PZ Sun, MT McMahon Preclin MRI Kidney 241, 2021 | 6 | 2021 |
| Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging P Irrera, M Roberto, L Consolino, A Anemone, D Villano, ... Metabolites 13 (1), 48, 2022 | 5 | 2022 |
| Dynamic contrast enhancement (dce) mri–derived renal perfusion and filtration: Basic concepts M Pedersen, P Irrera, W Dastrù, FG Zöllner, KM Bennett, SC Beeman, ... Preclinical MRI of the Kidney: Methods and Protocols, 205-227, 2021 | 5 | 2021 |
| Renal pH mapping using chemical exchange saturation transfer (CEST) MRI: experimental protocol KD Pavuluri, L Consolino, DL Longo, P Irrera, PZ Sun, MT McMahon Preclinical MRI of the Kidney: Methods and Protocols, 455-471, 2021 | 4 | 2021 |
| Dynamic Contrast Enhanced (DCE) MRI-derived renal perfusion and filtration: experimental protocol P Irrera, L Consolino, W Dastrù, M Pedersen, FG Zöllner, DL Longo Preclinical MRI of the Kidney: Methods and Protocols, 429-441, 2021 | 2 | 2021 |
| Analysis protocol for dynamic contrast enhanced (dce) mri of renal perfusion and filtration FG Zollner, W Dastrù, P Irrera, DL Longo, KM Bennett, SC Beeman, ... Preclinical MRI of the Kidney, 637, 2021 | 1 | 2021 |
| L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy BV Jardim-Perassi, P Irrera, OE Oluwatola, D Abrahams, VC Estrella, ... Biomedicines 12 (2), 461, 2024 | | 2024 |
| Neutralizing acidosis with L-DOS47 urease immunoconjugate enhances responses to anti-PD1 checkpoint blockade in a preclinical orthotopic model of pancreatic adenocarcinoma BV Jardim-Perassi, P Irrera, D Abrahams, CJ Whelan, MS Beatty, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
Dario Livio LongoIstituto di Biostrutture e Bioimmagini - CNRVerified email at unito.it
